An FDA reviewer is agreeing with Allergan that its glaucoma drug Lumigan also has an alluring side effect: it lengthens and thickens eyelashes. Allergan is seeking the agency's approval to sell the drug as Latisse to enhance upper eyelashes. And, as the Wall Street Journal notes, an approval would be a first for eyelash care. Report